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Human leukocyte antigens (HLA) have a pivotal role in immune response andmay be involved in antigen recognition of periodontal
pathogens. However, the associations of HLA with chronic periodontitis (CP) have not been previously studied in the Brazilian
population. In an attempt to clarify the issue of genetic predisposition toCP, we examined the distribution ofHLA alleles, genotypes,
and haplotypes in patients from Southern Brazil. One hundred and eight CP patients and 151 healthy and unrelated controls with
age-, gender-, and ethnicity-matched were HLA investigated by polymerase chain reaction with sequence specific oligonucleotides.
To exclude smoking as a predisposing factor, statistical analyses were performed in the total sample and in nonsmoking individuals.
The significant results showed a positive association of the A∗02/HLA-B∗40 haplotype with CP (total samples: 4.2% versus 0%, 𝑃
𝑐
= 0.03; nonsmokers: 4.3% versus 0%, 𝑃
𝑐
= 0.23) and a lower frequency of HLA-B∗15/HLA-DRB1∗11 haplotype in CP compared
to controls (total samples: 0.0% versus 4.3%, 𝑃
𝑐
= 0.04; nonsmokers: 0 versus 5.1%, 𝑃
𝑐
= 1.0). In conclusion, the HLA-A∗02/B∗40
haplotypemay contribute to the development of CP,whileHLA-B∗15/DRB1∗11 haplotypemight indicate resistance to disease among
Brazilians.
1. Introduction
Chronic periodontitis (CP) is a common complex disease
of the oral cavity that is characterized by an inflammatory
response to commensal and pathogenic oral bacteria [1,
2]. Due to bacterial infection, periodontal tissues become
inflamed and are slowly destroyed by the action of the
inflammatory process. If the disease is left untreated, teeth
lose their ligamentous supporting structure to the alveolar
bone, the alveolar bone is resorbed, and the teeth become
mobile, finally resulting in teeth loss [1]. CP is considered the
main cause of tooth loss among adults and is associated with
severe quality of life impact [3].
The inflammatory response of the periodontal tissues to
infection is influenced by environmental factors as well as by
genetic factors [4, 5]. It is estimated that 50%of the expression
of periodontitis in CP could be attributed to genetic factors
[5]. The observation that periodontitis is a complex disease
entity with a multifactorial etiology has led to the search for
risk factors that predispose to periodontitis in general as well
as distinctive risk factors that might predispose to different
clinical presentations of this group of diseases.
The human leukocyte antigens (HLA) play an important
role in immune responsiveness and may be involved in
antigen recognition of periodontal pathogens [6]. These cell-
surface molecules have a key role in antigen presentation and
activation of T cells.The polymorphisms of HLA can directly
affect the binding capability of antigen peptides and thus
affect the antigen-specific T-cell response [7]. Hence, these
polymorphisms could represent an important susceptibility
or resistance factor to periodontitis.
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For many years, researchers have periodically screened
populations of patients with different forms of periodontitis
for associations with HLA antigens [8–14] and consistent
results in relation to CP could not be obtained up to now.
This study aimed to investigate differences in allelic group,
genotype, and haplotype frequencies of HLA classes I and II
in a sample of Brazilian patients with CP compared with a
control group without CP.
2. Materials and Methods
2.1. Sample Selection. Between January and September 2012,
a total of 259 individuals were selected from those who
sought dental treatment at the dental clinics of Maringa
State University (UEM) and Inga University (UNINGA´) at
Maringa´, PR, Brazil (north/northwest region of the State of
Parana, located in the southern region of Brazil, between
22∘29󸀠30󸀠󸀠–26∘42󸀠59󸀠󸀠S and 48∘02󸀠24󸀠󸀠–54∘37󸀠38󸀠󸀠W). Males
and females, ethnically similar, aged over 34 years and with
at least 20 teeth in the buccal cavity participated in this study.
The criteria for exclusion were as follows: individuals with
acute infections or diseases with known associations to HLA
alleles such as diabetes, rheumatic diseases, systemic lupus
erythematosus or narcolepsy, use of antibiotics during the last
six months, and chronic usage of anti-inflammatory drugs or
lactations and those who were pregnant.
After taking the patient’s history, clinical periodontal
examinations were conducted by two examiners. Clinical
parameters of probing depth (PD) and clinical attachment
level (CAL) were examined at six sites (mesiovestibular,
vestibular, distovestibular,mesiolingual, lingual, and distolin-
gual) of each tooth, as was bleeding on probing (BOP). After
the periodontal examination, participants were categorized
into two different groups: the CP group (𝑛 = 108) composed
of individuals who had at least 5 sites in different teeth with
PD ≥ 5mm, CAL ≥ 3mm, and more than 25% of BOP; and
the control group (𝑛 = 191), formed by individuals who did
not have sites with reduced CAL, displayed a PD of less than
4mm, and exhibited less than 25% of BOP. Therefore, the
control group was matched to the case group according to
epidemiological characteristics such as ethnicity, gender, and
geographical region. Information on the habit of smokingwas
obtained by interviewing the individual (anamnesis).
2.2. Ethics Information. All individuals who agreed to partic-
ipate in this research were informed regarding the nature of
the study and signed an informed consent form authorizing
the use of their samples in the study, which was approved by
the Ethics Committee for Human Research at Maringa State
University (UEM-N∘.719/2011, 02/12/2011).
2.3. Sample Collection and DNA Extraction. Blood samples
(4mL) were collected from the subjects in tubes containing
anticoagulant (EDTA) and centrifuged at 210 g for 15minutes,
and the buffy-coat was conserved at −20∘C until use. The
genomic DNA was extracted using the salting-out method
described by Miller et al. [15]. The concentration and quality
of the DNA were analyzed by optical density in a Thermo
Scientific Nanodrop 2000 apparatus (Wilmington, USA).
2.4. HLA Genotyping. HLA typing (HLA-A, HLA-B, HLA-
C, DRB1, DQA1, and DQB1) was carried out using the poly-
merase chain reaction-sequence specific oligonucleotides
technique (PCR-SSO; One Lambda, Canoga Park, CA, USA),
low resolution to HLA-A, HLA-B, HLA-C, and DRB1, and
high definition to HLA-DQA1 and DQB1. First, target
DNA was PCR-amplified using group specific primers set,
after the amplified product was biotinylated, which allowed
later detection using R-phycoerythrin-conjugated strepta-
vidin (SAPE), and hybridized with microspheres linked to
specific conjugated fluorescent probes for HLA allele groups
(One Lambda, Canoga Park, CA, USA). The fluorescent
intensity varied based on reaction outcome and was expected
to be 1000 or above for control positive probes. Reaction
readings were carried out by flow cytometry using Luminex
technology (One Lambda). Samples were analyzed through
the HLA FUSION software (One Lambda Inc., San Diego,
CA, USA).
2.5. Statistics. HLA specificity frequencies between the
groups were compared using Fisher exact test. A two-sided
𝑃 value (𝑃) of <0.05 was considered statistically significant.
Odds ratio (OR) values with a 95% confidence interval (95%
CI) were also calculated to evaluate the risk of the individual
developing the disease when having a particular HLA type.
All the statistical analyses were performed using the 𝑅
statistical environment [16]. However, to account formultiple
comparisons, the observed 𝑃 values were corrected (𝑃
𝑐
) for
the number of alleles when one locus was considered alone
(Bonferroni correction). As the gametic phase of alleles from
the different loci was not known and segregation analysis into
families was not carried out, haplotypes and the calculation
of their frequency were determined by the likelihood ratio
test, through the Arlequin statistical software program [17].
Hardy-Weinberg equilibrium [18]was achieved by calculating
the expected genotype frequencies and comparing them to
the observed values, also using Arlequin statistical software
program [17]. To exclude smoking as a predisposing factor
statistical analyses were performed in the total sample (smok-
ers, ex-smokers, and nonsmokers: patientsversus control) as
well as in nonsmoking patients versus nonsmoking controls.
Only the haplotypes with frequencies above 1.0% were con-
sidered in this study.
3. Results
The study involved 259 individuals, 108 of whom were
patients with CP, while 151 controls were healthy individuals.
At the time of sample collection, the ages of the patients and
controls ranged between 34 and 81 years (47.22% males and
52.78% females by patients and 35.10% males and 64.90%
females by controls). Regarding the ethnic background,
59.26% of the patients with CP were reported to be Cau-
casians, 27.78% racially mixed, and 12.96% Afro-Brazilian.
Concerning the control individuals, 69.54% were reported
to be Caucasians, 23.84% racially mixed, and 6.62% Afro-
Brazilian. No differences were observed between patients and
controls according to gender, age, and ethnicity. Smoking was
associated with CP and was more frequent in patients than in
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Table 1: Characteristics of patients with chronic periodontitis and controls.
Category Subcategory
Patients Controls Total
(𝑁 = 108) (𝑁 = 151) (𝑁 = 259)
𝑛 (%) 𝑛 (%) 𝑛 (%)
Gender Female 57 (52.78) 98 (64.90) 157 (60.62)
Male 51 (47.22) 53 (35.10) 102 (39.38)
Age
34–49 years 65 (60.18) 97 (64.24) 162 (62.55)
50–65 years 35 (32.41) 50 (33.11) 85 (32.82)
66–81 years 8 (7.41) 4 (2.65) 12 (4.63)
Ethnic background
Caucasian 64 (59.26) 105 (69.54) 169 (65.25)
Afro-Brazilian 14 (12.96) 10 (6.62) 24 (9.27)
Racially mixed 30 (27.78) 36 (23.84) 66 (25.48)
Smoking
Smoker (A) 23 (21.30) 17 (11.26) 40 (15.44)
Nonsmoker (B) 46 (42.59) 108 (71.52) 154 (59.46)
Ex-smoker (C) 39 (36.11) 26 (17.22) 65 (25.10)
B versus A: P ≤ 0.002; OR = 0.32; 95% CI = 0.14–0.68.
B versus C: P ≤ 0.001; OR = 0.29; 95% CI = 0.15–0.54.
A versus C: P = 0.84.
Table 2: HLA associations between chronic periodontitis patients and controls.
HLA
Total∗
P 𝑃
𝑐
OR (95% CI)
Nonsmokers∗∗
P 𝑃
𝑐
OR (95% CI)Patients
𝑁 = 216
𝑛 (%)
Controls
𝑁 = 302
𝑛 (%)
Patients
𝑁 = 92
𝑛 (%)
Controls
𝑁 = 216
𝑛 (%)
A∗02 49 (22.7) 86 (28.5) 17 (18.5) 66 (30.6) 0.035 0.63 0.52(0.26–0.97)
A∗32 3 (1.4) 15 (5.0) 0.030 0.45 0.27(0.05–0.97) 1 (1.1) 15 (6.0)
B∗40 16 (7.4) 8 (2.6) 0.018 0.38 2.93(1.16–8.07) 9 (9.8) 7 (3.2) 0.025 0.60
3.22
(1.03–10.55)
DRB1∗08 17 (7.9) 11 (3.6) 0.048 0.58 2.26(0.97–5.45) 8 (8.7) 8 (3.7)
DQB1∗06:01 0 (0) 7 (2.3) 0.045 0.63 0 (0–0.96) 0 (0.0) 5 (2.3)
DQB1∗06:09 5 (2.3) 0 (0.0) 0.012 0.17 undf(1.29–undf) 0 (0.0) 0 (0.0)
undf = undefined.
∗Total group (smokers, nonsmokers, and ex-smokers patients and controls).
∗∗Nonsmoking group (patients and controls).
controls (𝑃 = 0.043; OR = 2.12; 95% CI = 1.02–4.51) as well
as in ex-smokers compared to controls (𝑃 = 0.001, OR = 2.7;
95% IC = 1.46, 5.05) (Table 1).
In all groups, the distribution of HLA genotypes was
confirmed to be in Hardy-Weinberg equilibrium (𝑃 ≥ 0.05
in the patients and in the controls).
The most common HLA types were the following: HLA-
A∗01, ∗02, ∗03, and ∗24 and HLA-B∗15, ∗35, ∗44, and ∗51,
similar to other previous reports in the north/northwest
region of the State of Parana [19]; this was an important con-
trol to demonstrate that the population was representative.
Table 2 presents the HLA classes I and II group allele
frequencies distribution only for the significant differences
between patients and controls. When comparing the HLA
class I frequencies between CP and controls, HLA-A∗32 had
a lower frequency in patients with CP (smokers, nonsmokers,
and ex-smokers) and HLA-A∗02 in nonsmokers group;
HLA-B∗40 had a higher frequency in CP total patients
and also in nonsmokers patients group; no significant dif-
ferences were found for HLA-C allelic groups. In relation
to class II, HLA-DRB1∗08 allelic group and DQB1∗06:09
were overrepresented in patients compared to controls, and
HLA-DQB1∗06:01 was less frequent in patients compared
with controls; however, neither of these associations was
confirmed in the nonsmoker group.
Differences between CP and controls were found com-
paring the HLA genotypes frequencies for homo- and het-
erozygosis. HLA-C∗03-C∗06 genotype was increased in
CP, whereas HLA-DQB1∗03:01 homozygous genotype and
DQB1∗03:01/DQB1∗03:02 were significantly less frequent in
CP (Table 3). After Bonferroni correction, the associations
lost the significance.
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Table 3: HLA genotype frequency associations between chronic periodontitis patients and controls∗.
HLA genotypes
Patients
𝑁 = 108
𝑛 (%)
Controls
𝑁 = 151
𝑛 (%)
P 𝑃
𝑐
OR (CI 95%)
C∗03-C∗06 4 (4.6) 0 (0) 0.012 0.56 undf (1.31–undf)
DQB1∗03:01-DQB1∗03:01 0 (0.0) 7 (4.6) 0.044 1.00 0 (0–0.95)
DQB1∗03:01-DQB1∗03:02 0 (0.0) 7 (4.6) 0.044 1.00 0 (0–0.95)
undf = undefined.
∗Total group (smokers, nonsmokers, and ex-smoking patients and controls).
Table 4: HLA haplotype associations between chronic periodontitis patients and controls∗.
HLA haplotypes
Patients
𝑁 = 216
𝑛 (%)
Controls
𝑁 = 302
𝑛 (%)
P 𝑃
𝑐
OR (95% CI)
A∗02/B∗40 9 (4.2) 0 (0.0) <0.001 0.03 undf (2.83–undf)
A∗03/B∗51 5 (2.5) 0 (0.0) 0.012 0.36 undf (1.29–undf)
A∗26/B∗38 5 (2.3) 0 (0.0) 0.012 0.36 undf (1.29–undf)
B∗40/C∗03 12 (5.6) 5 (1.7) 0.022 0.62 3.49 (1.12–12.83)
B∗18/C∗12 4 (1.9) 0 (0.0) 0.03 0.93 undf (0.93–undf)
B∗51/C∗01 4 (1.9) 0 (0.0) 0.30 0.93 undf (0.93–undf)
B∗15/DRB1∗11 0 (0.0) 13 (4.3) 0.001 0.04 undf (0–0.45)
B∗40/DRB1∗07 6 (2.8) 0 (0.0) 0.005 0.19 undf (1.67–undf)
B∗50/DRB1∗04 4 (1.9) 0 (0.0) 0.030 1.14 undf (0.93–undf)
DQA1∗01:02/DQB1∗06:09 5 (2.3) 0 (0.0) 0.012 0.23 undf (1.30–undf)
DRB1∗13/DQA1∗01:02/DQB1∗06:09 5 (2.3) 0 (0.0) 0.012 0.25 undf (1.29–undf)
undf = undefined.
∗Total group (smokers, nonsmokers, and ex-smoking patients and controls).
Bold font: significant after Bonferroni correction.
Regarding haplotype frequencies (Tables 4 and 5) patients
with CP had significantly higher frequencies for HLA-A∗02/
HLA-B∗40 and a lower frequency for HLA-B∗15/HLA-
DRB1∗11. Furthermore, patients with CP (only total sam-
ples) had higher haplotypes frequencies for B∗18/C∗12,
B∗51/C∗01, B∗50/DRB1∗04, DQA1∗01:02/DQB1∗06:09, and
DRB1∗13/DQA1∗01:02/DQB1∗06:09 (Table 4); for non-
smokers B∗44/DRB1∗07, B∗35/DRB1∗11, and B∗14/DRB1∗01
were more frequent and HLA-A∗02/HLA-B∗35 was less
frequent in patients compared to controls (Table 5);
A∗03/B∗51, A∗26/B∗38, B∗40/C∗03, and B∗40/DRB1∗07
(Tables 4 and 5) had higher frequencies for both groups,
although for all of them the significance was lost after
Bonferroni correction.
4. Discussion
While many studies have shown associations of HLA poly-
morphisms with aggressive periodontitis in different pop-
ulations [8, 10–14, 20–24] there are few studies of HLA
association with CP and the results are inconsistent [9–11,
20, 25–27]. To the best of our knowledge, this is the first
study ofHLAassociationwithCP in the Brazilian population.
Our results provide evidence that HLA classes I and II are
associated with chronic periodontitis.
In general, discrepancies in results are observed in HLA
case-control studies, and these discrepancies could be caused
by differences in the choice of controls, disease diagnostic,
racial background, and statistical analyses [28]. In this study,
in order to avoid bias in the final results, the control
population was selected after clinical examination with the
same criteria used for patient exclusion, such as gestation
and manifestations of infectious disease or known medi-
cal conditions that may contribute to development of CP.
Patients with aggressive periodontitis were also excluded.
Other confounding variables as gender, age, and ethnicity
were considered. Gender and age ratio was similar between
patients and controls. Reichert et al. [20] warned against
the fact that gender could represent a confounding variable
that should be considered in HLA and periodontitis studies;
however, as HLA antigen expression has been reported to
not vary as a function of gender [29, 30], this expression was
probably not taken into consideration in many of the earlier
studies on HLA association for periodontal diseases [10, 11,
13, 27, 31]. Age was not related to HLA expression but can be
related to the disease, although severity and prevalence were
mostly related to past disease history, social and behavior
factors [32], and altered inflammatory responses [33].
Important to emphasize is that HLA varies according to
population and ethnic group and that Brazil has an admixed
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Table 5: HLA haplotype associations between nonsmokers, chronic periodontitis patients, and controls.
HLA haplotypes
Patients
𝑁 = 92
𝑛 (%)
Controls
𝑁 = 216
𝑛 (%)
P 𝑃
𝑐
OR (95% CI)
A∗02/B∗40 4 (4.3) 0 (0.0) 0.008 0.23 undf (1.58–undf)
A∗02/B∗35 0 (0.0) 11 (5.1) 0.038 1.00 0 (0–0.91)
A∗03/B∗51 3 (3.3) 0 (0.0) 0.026 0.75 undf (0.98–undf)
A∗26/B∗38 3 (3.3) 0 (0.0) 0.026 0.75 undf (0.98–undf)
B∗40/C∗03 7 (7.6) 4 (1.9) 0.019 0.51 4.34 (1.07–20.75)
B∗44/B∗07 4 (4.3) 1 (0.5) 0.029 0.78 9.69 (0.94–482.15)
B∗15/DRB1∗11 0 (0.0) 11 (5.1) 0.038 1.00 0 (0–0.91)
B∗40/DRB1∗07 4 (4.3) 1 (0.5) 0.029 0.81 9.69 (0.94–482.15)
B∗35/DRB1∗11 4 (4.3) 1 (0.5) 0.029 0.81 9.69 (0.94–482.15)
B∗14/DRB1∗01 4 (4.3) 0 (0.0) 0.008 0.22 undf (1.58–undf)
undf = undefined.
population. The population in Parana has been well defined
regarding ethnicity and HLA distribution: in accordance
with HLA phenotypic classification, the white population
(majority) is predominantly of European origin (80.6%), with
a smaller contribution of African (12.5%) and Amerindian
(7.0%) genes [34]. Thus, regarding ethnic backgrounds, peri-
odontitis patients and controls were similar, not representing
a confounding variable. For this reason added to the high
polymorphism of HLA, stratification by ethnicity was not
realized.
In this study, as expected, smoking was associated with
CP and having stopped smoking maintained susceptibility to
disease. As smoking is a risk factor for the onset and progres-
sion of CP and the habit can obscure genetic risk factors [35]
we analyzed nonsmoking patients and nonsmoking controls
in addition to the total group (smokers, ex-smokers, and
nonsmokers).
In the current study some trends to associations of HLA
class I antigens with CP were found. HLA-A∗32 was less
frequent in total samples and HLA-A∗02 was less frequent in
nonsmoker patients representing possible protection to CP;
however, significance was lost after Bonferroni correction.
Added to these results, the HLA-A∗02/B∗35 haplotype was
significantly less frequent in nonsmoker patients. Similar to
our results, pioneering and recent investigations involving
periodontitis and HLA have also found HLA∗02 associated
with protection to periodontitis [25, 27, 36, 37]. Thus, our
results indicate a protective role of HLA-A∗02. A2 could yield
an efficient antimicrobial T-cell response reducing the disease
[25].
Otherwise, HLA-B∗40 was more frequent in both groups
representing a risk effect against CP, although significance
was also lost after Bonferroni correction. However, HLA-
A∗02/B∗40 haplotype was significantly associated with sus-
ceptibility to CP. Added to this result, HLA-B∗40/C∗03
and HLA-B∗40/DRB1∗07 haplotypes tend to be associated
with CP susceptibility. As HLA-A∗02/B∗40 was in linkage
disequilibrium (Δ󸀠 > 0.70, for all analyzed population:
patients and controls) and HLA-A∗02 has been associated
as a protection factor, the susceptibility found for patients
with CP may be related to HLA-B∗40. Individuals carrying
B∗40 (B60 and B61 antigens) had a three-fold higher risk of
developing the disease. Contrarily, in another reporter, HLA-
B∗40 was associated with a lower clinical attachment loss
in CP; however, this association was lost after Bonferroni
correction [31].
Taking into account other haplotypes that were sig-
nificantly associated in our population, the HLA-B∗15-
DRB1∗11 combination must be highlighted conferring pro-
tection against CP in the total group of patients. HLA-B∗15-
DRB1∗11 was in linkage disequilibrium (Δ󸀠 > 0.80 for all
analyzed population). HLA-B∗15 could be associatedwith the
disease: no associations between DRB1∗11 and CP have been
previously reported; however, in agreement with our results,
Mauramo et al. [31] found that patients expressing HLA-B∗15
had less clinical periodontal disease manifestation and better
periodontal health over a long period of time. HLA-B∗15
positive individuals might have a somewhat peculiar genetic
response towards periodontal bacteria challenge contributing
to CP development [31].
Another haplotype that lost the significance after Bon-
ferroni correction in our study but must be highlighted
wasHLA-B∗50/DRB1∗04.This haplotypewas a susceptibility
factor to CP in our population and it is possible that the
effect was associated with DRB1∗04. According to previous
reports, and in agreement with our results, HLA-DRB1∗04
was associated with risk to CP [38, 39] and aggressive
periodontitis [9, 12, 23, 30], as well as their alleles [8, 30].
DRB1∗04:04 was considered a risk factor for bone loss [30,
40]. Contrarily, in a recent investigation, HLA-DRB1∗04 or
HLA-DRB1∗04/DRB4∗(DR53)/DQB1∗03:02 haplotype had
a decreased colonization risk of Aggregatibacter actino-
mycetemcomitans [9]. DRB1∗04 was an immunogenetic sus-
ceptibility factor for type 1 diabetes [41] and for rheumatoid
arthritis [30]; however, both diseases were included in our
exclusion criteria.
According to other association studies between peri-
odontitis and HLA, a meta-analysis focusing on Caucasian
case-control studies conducted by Stein et al. [25] demon-
strated no associations between HLA and CP, although for
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aggressive periodontitis HLA-A∗09 and B∗15 appeared to
represent susceptibility factors andHLA-A∗02 andB∗05were
potential protective factors. OtherHLA-A,HLA-B, andHLA-
C associations with periodontal disease previously described
in the literature were as follows: susceptibility mediated by
HLA-A∗11, A∗29, B∗14, and C∗08 and protection by HLA-
A∗03, HLA-A∗31 and -A∗30/A∗31 genotype observed in
German patients with CP [11] and HLA-B∗57 as a protecting
factor in German patients with CP or generalized aggressive
periodontitis [9]; HLA-A∗02 and HLA-B∗05 associated with
protection in the CP patients from USA [27, 36, 37]; HLA-
A∗09 positively associated with CP from France [26]; and
HLA-B∗51 related to fewer deep periodontal pockets in the
CP in Swiss adults. HLA-DQA1∗03 andHLA-DRB1∗04 were
higher and HLA-DQB1∗06:03 might have protective effects
against aggressive periodontitis in Iranian patients [8].
A possible role of HLA in the immune response and
development of periodontal disease may be related to their
ability to bind some processed peptides from bacteria anti-
gens and expressing themon the surface of antigen presenting
cells (peptide-HLA class II) or target cells (peptide-HLA
class I) in order to present them to T cells (CD4 or CD8)
[42]. The binding capacity of the bacteria peptide depends
on HLA allotypic structure of their paratope. Failures in
this link capacity can compromise the immune response
and could be a risk of disease. The large individual capacity
of immune response occurs due to the fact that HLA is
highly polymorphic: each gene has multiple alleles and each
individual has many expressed genes. These preliminary
results indicate that HLA haplotypes might be involved in
the susceptibility or risk for periodontal disease. However,
further investigations of HLA haplotypes markers in relation
to antigenic peptide-binding motifs are necessary in order to
understand its relation in periodontitis.
The weaknesses of the case-control studies were related
to the reproduction of results in function of ethnicity
background of the individuals, sample size, diagnostic tolls
of disease, and HLA genotyping methods. Consequently,
no strong association could be found, especially in CP. In
addition, CP is a complex and multifactorial disease and
several other genetic polymorphisms have been reported
to be associated with bacterium response, inflammation,
chronicity, and wide ranging systemic effects and disease
development, such as IL1, IL4, TNF, IL8, and IL10 cytokines
genes, immunoglobulin G Fc receptor (FcyR), and TLR [35,
43–60]. Despite this fact, all information regarding genetic
susceptibility to diseases is valuable and can be applied
to therapy intervention or individual approach. For better
results, we have tried to be very critical in the choice of the
study population. CP inclusion criteria and CP and control
exclusion criteria were defined in order to avoid confounding
factors and were a representative of generally healthy and CP
adults. As independent multiple comparisons were carried
out and we considered that all genotypes examined had
the same chance of being increased or decreased in CP,
Bonferroni correction was applied for all significant 𝑃 values.
The present study has potential limitations. We focused
on the HLA allele group, not on alleles and epitopes analysis,
and split antigens were not investigated.Themajor limitation
of this study is the relatively small sample size regarding the
analysis of the nonsmoker group.
In these Brazilian CP patients, the HLA-A∗02/B∗40
haplotype was considered a risk factor for CP and HLA-
B∗15/DRB1∗11 haplotype was considered a protective factor
for disease. Susceptibility may possibly be associated with
B∗40 molecules and protection may be associated with B∗15
and A∗02. Further investigation relating antigenic peptide-
binding motifs and their immunopathogenesis involving CP
development should be investigated.
5. Conclusion
These results provide evidence that class I and II HLA
polymorphisms are associated with chronic periodontitis.
HLA-A∗02/B∗40 haplotype seems to represent susceptibility
factors and HLA-B∗15/DRB1∗11 haplotype was potential
protective factors against disease.
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